These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2569324)

  • 1. Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.
    Calès P; Grasset D; Ravaud A; Meskens C; Blanc M; Vinel JP; Cotonat J; Pascal JP
    Br J Clin Pharmacol; 1989 Jun; 27(6):763-70. PubMed ID: 2569324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension.
    Calès P; Caillau H; Crambes O; Vinel JP; Desmorat H; Rocher I; Jung L; Urien S; Brouard R; Pascal JP
    J Hepatol; 1993 Aug; 19(1):43-50. PubMed ID: 7905493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.
    Nicholls DP; Harron DW; McAinsh J; Castle WM; Barker NP; Shanks RG
    Br J Clin Pharmacol; 1982 Nov; 14(5):727-32. PubMed ID: 7138752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients.
    Vorobioff J; Picabea E; Villavicencio R; Puccini V; Rossi O; Bordato J; Audano M
    Hepatology; 1987; 7(4):648-53. PubMed ID: 3610045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
    Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
    J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
    Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
    Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship among beta-adrenergic blockade, propranolol concentration, and liver function in patients with cirrhosis.
    Caujolle B; Ballet F; Poupon R
    Scand J Gastroenterol; 1988 Oct; 23(8):925-30. PubMed ID: 3201129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
    Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
    J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
    Elliott HL; Meredith PA; McNally C; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):379-85. PubMed ID: 1777376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J; Degen PH; Racine-Poon A
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
    Conn HO; Grace ND; Bosch J; Groszmann RJ; Rodés J; Wright SC; Matloff DS; Garcia-Tsao G; Fisher RL; Navasa M
    Hepatology; 1991 May; 13(5):902-12. PubMed ID: 2029994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
    Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J
    Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic and pharmacokinetic studies on bufuralol in man.
    Pringle TH; Francis RJ; East PB; Shanks RG
    Br J Clin Pharmacol; 1986 Nov; 22(5):527-34. PubMed ID: 2878678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.